Immune Checkpoint Inhibition for Locally Advanced NSCLC: Time to Ask New Questions?

J Thorac Oncol. 2022 Dec;17(12):1330-1332. doi: 10.1016/j.jtho.2022.08.019.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • B7-H1 Antigen / therapeutic use
  • Carcinoma, Non-Small-Cell Lung* / drug therapy
  • Humans
  • Immune Checkpoint Inhibitors
  • Lung Neoplasms* / drug therapy

Substances

  • Immune Checkpoint Inhibitors
  • B7-H1 Antigen